Recent Headlines
Within Pharmaceuticals
Advanced Orthopedics and Sports Medicine Institute Revolutionizes Knee Replacement Procedures for Women
The orthopedic surgeons at the Advanced Orthopedics and Sports Medicine Institute, PC (AOSMI) are among the first surgeons in the Freehold, New Jersey area to offer the Zimmer® Gender Solutions™ Knee, which is the first and only knee replacement shaped to fit a woman’s anatomy. - July 11, 2007 - Advanced Orthopedics and Sports Medicine Institute, PC
Magellan BioScience Group, Inc. Awarded SBIR Grant for anti-Malarial Drug Discovery Collaboration with University of South Florida
Magellan BioScience Group, Inc. (Magellan), a pioneer in innovative drug discovery and development from marine microbial sources, and the University of South Florida (USF) announced today that they have been awarded a Phase I Small Business Innovative Research Grant (SBIR) from the National... - July 06, 2007 - CoreRx, Inc.
Second Annual “XanGo Cup” to Feature Pioneer Holiday RSL Friendlies with Elite Clubs Everton and Boca Juniors
Events Include Official Opening of RSL’s New XanGo Campus Practice Field - June 29, 2007 - XanGo, LLC
Baxa Corporation Features Pharmacy Training Programs, Abacus™ Software and ValiMed™ Medication Validation System at the ASHP Summer Meeting
Baxa Corporation is promoting its industry-leading STAR Center pharmacy training facility, CriticalPoint™ online sterile compounding certification training, Abacus TPN ordering and calculation software and the ValiMed System for medication validation at the American Society of Health-System Pharmacists 2007 Summer Meeting and Exhibition beginning today at the Moscone Center in San Francisco. - June 25, 2007 - Baxa Corporation
PharmaChem Publishes AnaSpec Article on Peptides as Antigens
The June issue of PharmaChem, an Italian journal covering the drug discovery industry, featured an article written by AnaSpec called “Peptides as Antigens.” The technical article, written by Dr. Daniel Li and Cecilia Po, outlines the advantages and methodologies behind using peptides as... - June 24, 2007 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyte™ Beta-Secretase Assay Kit
Leveraging one of the world’s largest collections of amyloid peptides, AnaSpec has introduced its latest development in novel solutions for amyloid-related research - the new SensoLyte™ 520 Beta-Secretase Assay Kit. Beta-secretase catalyzes a key step in the production of beta-amyloid... - June 22, 2007 - AnaSpec, EGT Group
Gamma Medica-Ideas Announces First Sale of a Dual-Head LumaGEM® Molecular Breast Imaging System
Gamma Medica-Ideas Inc. (GM-I), a leader in providing next-generation medical imaging devices for the pre-clinical and clinical markets, announced today the sale of a dual-headed LumaGEM® system for applications such as Molecular Breast Imaging (MBI). This dual head system is the first of its... - June 22, 2007 - Gamma Medica-Ideas
MenScience Acne Spot Repair Gives New Meaning to "In Your Face"
For the majority of men, acne flare-ups do not end with the teen years. Whether it’s a lone pimple or a full-on breakout, acne is an irritating condition that plagues men throughout their lives. It’s because of this that MenScience has created a product that targets pimples and... - June 20, 2007 - MenScience Androceuticals
Baxa Corporation and Health Robotics Announce Strategic Alliance to Automate IV Admixture Preparation
Baxa Corporation and Health Robotics announce a strategic alliance to use the Baxa Two-Fer™ Needles with Health Robotics’ CytoCare™ Robot in order to safely and accurately automate the preparation of patient-specific chemotherapy IV admixtures. This alliance combines state-of-the-art technologies to achieve the accuracy and sterility that providers require. The resulting technology is the only totally automated system for handling hazardous IV admixtures available in the market. - June 18, 2007 - Baxa Corporation
University of Kuopio’s A.I. Virtanen Institute Uses Gamma Medica-Ideas’ FLEX Multi-Modality System to Image Baculovirus Biodistribution in Pre-Clinical Subjects
A team of researchers at University of Kuopio’s A.I Virtanen Institute for Molecular Sciences in Finland is conducting studies in non-invasive imaging with Gamma Medica-Ideas’ MicroSPECT/CT system to provide essential information on biodistribution of gene therapy vectors in rats. The... - June 17, 2007 - Gamma Medica-Ideas
Gamma Medica-Ideas Introduces High Resolution CT Subsystem
Gamma Medica-Ideas (GM-I) announced today the addition of a new High Resolution CT subsystem to the company’s FLEX Triumph™ Pre-clinical Imaging Platform that produces striking improvements in CT imaging. The new CT subsystem contains a variable focal spot x-ray source which provides... - June 17, 2007 - Gamma Medica-Ideas
Thrombotargets Corp. and Magellan Bioscience Group, Inc. to Collaborate on Identification of Novel Hits from Both Marine Derivate and Natural Products
Thrombotargets Corporation and Magellan Bioscience Group, Inc. today announced the formation of drug discovery joint venture. Under the terms of this agreement, Magellan Bioscience Group, Inc. will provide to Thrombotargets its compounds and extracts from fermentation broths of marine-isolated... - June 16, 2007 - CoreRx, Inc.
AnaSpec Introduces Industry’s First and Only Anti-MOG ELISA Kits
Drawing on its broad portfolio of MOG (35-55) and other multiple sclerosis (MS) experimental autoimmune encephalomyelitis (EAE)-related peptides, AnaSpec has just released its new line of SensoLyte™ Anti - MOG ELISA Kits - the industry’s first and only anti-MOG ELISA kits. Myelin... - June 16, 2007 - AnaSpec, EGT Group
ValiMed™ Medication Validation System And Related Information From Baxa Corporation Are Now Available At PublicRelationsNewsroom.com
The ValiMed Medication Validation System and related information are now available at PublicRelationsNewsroom.com. The ValiMed System, distributed by Baxa Corporation, offers clinicians a simple and cost-effective tool to ensure medication safety by verifying that medications are correctly compounded. Its patented technology validates compounded doses of high risk medications prior to dispensing. - June 15, 2007 - Baxa Corporation
Baxa Corporation Recognized by Medical Device & Design Industry Magazine for World-Class Quality Team
Baxa Corporation is profiled as one of eight world-class quality and regulatory teams in the June 2007 issue of Medical Device & Diagnostic Industry magazine. The June article was the first time MD&DI recognized the accomplishments of the quality and regulatory teams that ensure medical products are safe and ready for market. - June 13, 2007 - Baxa Corporation
Metamize365 Introduced – Set to Combat the Over-Looked Issue of Metabolic Syndrome
Dr. Steven Lamm announced yesterday the introduction of his new dietary supplement, Metamize 365. The product is aimed to help combat the often-overlooked metabolic syndrome problem in the US. "Over 50% of Americans have a problem with their metabolism. This often leads to diabetes, heart... - June 13, 2007 - Metamize 365
AnaSpec Prepares Technical Poster about Beta-Secretase Assay for Experimental Biology 2007
At the 2007 Experimental Biology conference in Washington, DC, AnaSpec prepared a technical poster entitled, "A Sensitive Fluorimetric Assay for Detection of beta-Secretase Activity Using a Novel FRET Peptide Substrate." The poster documented the following findings: • A highly... - June 08, 2007 - AnaSpec, EGT Group
Clinical Trials in Russia. 1st Quarter 2007 Results
According to Synergy Research Group, a Russia-based CRO, the growth in the number of clinical trials approved by the Russian Federal Agency for Health Care and Social Development (Roszdravnadzor) made up to nearly 40% in the 1st Quarter of 2007 as compared to the same quarter of the previous year. At the same time, the share of clinical studies initiated by Russian manufacturers has increased. - June 06, 2007 - Synergy Research Group
Functional Genetics, Inc. Receives Award to Discover New Opportunities to Combat HIV Infection
Functional Genetics, Inc. Announces a New Award from the National Institute of Allergy and Infectious Diseases to Utilize Its Core Random Homozygous Gene Perturbation and Host-Oriented Therapeutics Technologies to Identify and Validate New Therapeutic Approaches to Combat HIV Infection - June 03, 2007 - Functional Genetics, Inc.
Summer Fun for Dad and Son This Father’s Day, Give a Dad a Gift That Shines
June ushers in Father’s Day and Sun Safety Week, so in honor of both, MenScience is awarding a ‘Dad that Shines the Brightest Award’. The winner will receive the entire MenScience Father’s Day sun care gift set, complete with the TiO2 Sunblock SPF 30, Advanced Lip... - June 01, 2007 - MenScience Androceuticals
Tias Arms Announces 6th Annual Event “Art Party in the Park” to Raise Funds for Orphaned and Abandoned Children Affected by HIV/AIDS in South Africa
Tias Arms announced today that its 6th annual celebration and fundraising event, this year entitled “Art Party in the Park”, will be held on Sunday, June 10th from 12 noon to 5pm at Park Prive in Costa Mesa. As in previous years, this exciting event will include a silent and live... - June 01, 2007 - Tias Arms
The Imminent Change of the Antithrombotics Market
The antithrombotics market with the two blockbusters enoxaparin and prasugrel is challenged by generic products as well as by next generation anticoagulants with oral administration and antithrombotics with an improved risk-benefit ratio - June 01, 2007 - La Merie Business Intelligence
Novel Agent for Reactive Metabolite Detection
Bioactivation of drug candidates resulting in chemically reactive, electrophilic metabolites have always presented a major challenge to pharmaceutical companies. Moreover, the measurement of these metabolites has been hampered by the lack of an effective quantitative method. QA-GSH is a novel new... - May 31, 2007 - AnaSpec, EGT Group
Colorado BioScience Association Applauds Governor Ritter’s Signing of HB 1060 As Critical To Future Growth of The State’s Bioscience Industry
Colorado Governor Bill Ritter signed House Bill 1060 into law Wednesday afternoon, with the bill sponsors present to acknowledge the importance of the legislation to the bioscience industry in Colorado. Rep. Jim Riesberg (D-Weld) and Sen. Brandon Shaffer (D-Longmont) were thanked for their efforts... - May 25, 2007 - Colorado BioScience Association
Xcelience Will Acquire New Technologies to Enhance Drug Development Processes
The Tampa-based Contract Research Organization signed a partnership that will form new opportunities in the pharmaceutical industry. - May 24, 2007 - Xcelience, LLC
Zoft Gum Company Launches New Product to Ease the Pain of Menopause
Zoft Menopause Gum offers relief for menopausal symptoms in a convenient chewing gum product. - May 23, 2007 - Zoft Gum Company
AnaSpec Introduces Line of Insulin Receptor Antibodies
The insulin receptor is a transmembrane receptor that belongs to the tyrosine kinase receptors class. It is a heterotetrameric glycoprotein composed of disulfide-linked subunits in a β-α-α-β configuration. This transmembrane receptor consists of 95kDa β-subunit, a single... - May 23, 2007 - AnaSpec, EGT Group
Baxa Ltd, Subsidiary of Denver-based Baxa Corporation, Announces Direct Sales and Marketing Operations in Switzerland
Baxa Ltd, subsidiary of Denver-based Baxa Corporation, has moved to a direct sales and marketing model for the Swiss market. The company provides systems and devices for simplifying the handling, mixing and administration of fluid medications. Direct operations will provide Baxa Ltd with improved customer access for product development and continuous improvement, while continuing their excellent customer service. - May 21, 2007 - Baxa Corporation
Colorado BioScience Association Names Jack Wheeler Chairperson, Announces 2007 Sponsors and Appoints Eight New Board Members
Jack Wheeler, CEO of MicroPhage, Inc., Longmont, is the new chairperson of the board of directors for the Colorado BioScience Association (CBSA). He was appointed at the association’s 2007 annual meeting April 24th. Wheeler assumes chairperson responsibilities from Ed Wood, ArcScan, Inc. In other action, eight new board members were appointed to three-year terms. - May 18, 2007 - Colorado BioScience Association
Industry’s First West Nile Virus Protease Assay Kits
While West Nile virus (WNV) has had significant outbreaks throughout the world since it was first identified, commercially available assay kits for the detection of WNV protease inhibitors had not been developed until now. With the SensoLyte™ series of WNV Protease Assay Kits AnaSpec, a... - May 17, 2007 - AnaSpec, EGT Group
Baxa Corporation Wins BMA Colorado 2007 Gold Key Award
Baxa Corporation's direct marketing campaign for the Rapid-Fill™ Automated Syringe Filler was awarded a Business Marketing Association Gold Key in the Colorado Chapter’s 2007 competition. Three messages: Safety is Automatic, Technology that Fits and Designed for Speed emphasized the key attributes that differentiate the Baxa product from competitive products and processes. - May 16, 2007 - Baxa Corporation
Clinical Trials in Russia - First Issue of SynRG Orange Paper
On April 25, 2007, the first issue of the Orange Paper – the first analytical review on market of clinical trials in Russia – was officially presented. The strategic goals of Synergy Research Group, a Russia-based emerging CRO, are formation of a civilized market of clinical trials in... - May 16, 2007 - Synergy Research Group
CoreRx, Inc. Announces New Expanded Capabilities
CoreRx, Inc. is an American owned company located in Tampa, Florida. CoreRx, Inc. announces the expansion of it’s capabilities including DEA licensure for controlled substances. This gives CoreRx, Inc. the ability to work with DEA schedule 2-5 active pharmaceutical ingredients and drug... - May 12, 2007 - CoreRx, Inc.
Futuristic Sleep Machine Now Reality
Those seeking improved sleep can switch on Sleep on Command™ device designed to enforce Delta rhythm sleep and the recovery that best occurs during deep, slow-wave, Delta-stage sleep. - May 08, 2007 - EarthPulse Tech, LLC
Age Defying Collagen Capsule Made in NZ
Puraz Health’s product - 100% Collagen, contains pure collagen and is manufactured in New Zealand. The unique design of the capsules means that collagen can be distributed to where it may have depleted: to joints, ligaments and to the biggest organ, the skin. This means that collagen, in the past only available to plastic surgeons, is now available to the whole body in natural capsule form. - May 08, 2007 - Puraz Health
Baxa Corporation Signs Co-Marketing Agreement with CriticalPoint for Interactive Web-Based Training
Baxa Corporation announces its agreement with CriticalPoint LLC to co-market a Web-based sterile compounding curriculum authored by internationally recognized subject matter experts. This comprehensive, ACPE-approved program consists of 32 modules that meet USP Chapter 797’s competency assessment requirements. Modules are self-paced and part of CriticalPoint’s Learning Management System (LMS), offering access from any Web connection and providing administrative reporting for tracking. - May 07, 2007 - Baxa Corporation
2007-08 Bioscience Colorado Magazine Debuts at BIO International Convention in Boston
Colorado Bioscience Association is releasing the new edition of Bioscience Colorado Magazine at the 2007 BIO International Convention, May 6-9, at the Boston Convention & Exhibition Center. This year’s magazine has expanded to 80 pages and includes an updated directory of the Colorado Bioscience industry: Medical Device and Related Companies; Biotechnology, Pharmaceutical and Related Companies; Biofuels and Related Companies; Research & Education Institutions; Foundations; & Service Providers. - May 06, 2007 - Colorado BioScience Association
New Research Presented by MD Anderson and University of Utah Verifies Dry Connections with PhaSeal
New evidence-based research was presented at ONS Congress by MD Anderson and the University of Utah which concluded only the PhaSeal System confined the drug, thus proving the prevention of drug exposure from preparation through administration of hazardous drugs. - May 05, 2007 - Carmel Pharma
“Premature Infants Safer Because Of New Feeding System,” Case Study Now Accessible at PublicRelationsNewsroom.com
“Premature Infants Safer Because Of New Feeding System,” a case study from Premier, Inc., and its member hospitals, in collaboration with Baxa Corporation and VIASYS MedSystems, is now accessible at PublicRelationsNewsroom.com. According to the case, thanks to the collaboration, tiny infants receiving nutrition through feeding tubes now face far less danger from the risk of IV lines and feeding tubes being accidentally connected. - May 03, 2007 - Baxa Corporation
Carmel Pharma, Inc. Launches New PhaSeal Preparation Component
Carmel Pharma, Inc. launches their new Protector 28 (P28). This preparation component is the latest advancement of the PhaSeal System and is available now. - May 03, 2007 - Carmel Pharma
Training Makes a Difference: New Study Finds Farmer Production Costs Decreased, Farmer and Food Safety Increased
Farmers were able to reduce their costs of production, while more effectively controlling pests and better protecting themselves and their farms – all thanks to a practical training programme with farmers in rural China. “Responsible use of crop protection products increases food... - May 01, 2007 - CropLife Asia
Baxa Corporation Announces Enteral Syringes Now on Contract with AmeriNet, MedAssets, Novation and Premier Group Purchasing Organizations
Baxa Corporation announces its new syringes, designed for enteral feeding only, have been accepted on contract with key group purchasing organizations to facilitate hospital compliance with patient safety goals and to prevent wrong-route errors. Contracts for enteral syringes have been made between Baxa and these top US group purchasing organizations: AmeriNet, MedAssets, Novation and Premier. - April 30, 2007 - Baxa Corporation
Artificial Sun for Cell Culture Heating
The LAMBDA MINIFOR fermenter / bioreactor provides a new heating system for precise, fast and economic heating of the culture medium in fermentation and cell culture processes - April 29, 2007 - LAMBDA Laboratory Instruments
Personalized Lab Services, LLC Offers New, Next-Day HIV-1 Test with +99.9% Proven Accuracy
Personalized Lab Services, LLC that distributes the only U.S. Food and Drug Administration (FDA)-approved at-home HIV-1 test, announced today that it has begun providing next business day results for its Express HIV-1 Test System. The accelerated, next business-day results continue to provide the... - April 28, 2007 - Personalized Lab Services, LLC
MenScience Tackles Men's Heart Health with the Omega 3 Supplement Formula
Because of the many benefits displayed by Omega-3 in its role in men’s cardiovascular health, MenScience has created the Omega 3 Supplement Formula. Its pharmaceutical-grade formula incorporates a high dose (1500 mg) of Omega-3 fatty acids to help protect men’s cardiovascular health, promote healthy brain function and mood levels, and increase joint and muscle mobility. - April 26, 2007 - MenScience Androceuticals
Carmel Pharma Offers New Continuing Education Program
Carmel Pharma, manufacturers and distributors of PhaSeal, announced today that they are now offering an accredited continuing education (CE) program developed by STAT Educational Services, an accredited provider of continuing education for various healthcare professionals. - April 25, 2007 - Carmel Pharma
New Medical Breakthrough: FDA Approved Device Can Turn Deadly Oral Cancer Into Treatable Cancer
A new breakthrough technology sets new oral tissue screening standards, enabling cancerous lesions to be diagnosed that may be undetectable under regular overhead white dental lights. The new device, VELscope, uses blue excitation light and a specialized filter to help dental professionals screen... - April 24, 2007 - Dentistry For Health New York, PLLC
Baxa Corporation Features Pharmacy Automation and Dedicated Oral Dispensers at the Interphex 2007 Exhibition
Baxa Corporation is promoting its industry-leading products for automating pharmacy filling operations and safe dispensing of oral liquid medications at the annual Interphex Conference and Exhibition beginning today at the Jacob K. Javits Convention Center in New York City. The annual Interphex Conference brings together global companies serving the pharmaceutical and biotechnical industries. - April 24, 2007 - Baxa Corporation
Interleukin & Chemokine Antibodies – Two Types of Cytokine Antibodies
Interleukin-32 (IL-32), whose expression is increased following activation by IL-2, was initially identified as a transcript (NK4) selectively expressed in lymphocytes and NK cells.1 - April 18, 2007 - AnaSpec, EGT Group
Baxa Praises the UK’s NPSA Patient Safety Alert Advising Hospitals to Switch to Safer Oral/Enteral Syringes
The UK’s National Patient Safety Agency (NPSA) has released a Patient Safety Alert detailing the hazards of wrong-route administration and recommending immediate actions to ensure that oral/enteral medications cannot be administered through an intravenous connection. Hospitals can comply with the Patient Safety Alert immediately using the Exacta-Med® Oral/Enteral Dispensers from Baxa Ltd, Baxa Corporation’s UK subsidiary. - April 17, 2007 - Baxa Corporation